Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy?

Similar documents
Robotic Surgery for Upper Tract Urothelial Carcinoma. Li-Ming Su, MD

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer

A patient with recurrent bladder cancer presents with the following history:

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Role and extension of lymph node dissection in kidney, bladder and prostate cancer. Omar Ghanem (PGY3 ) Moderator: Dr A. Noujem 30 th March 2017

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer

Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up

Index. B Balkan endemic nephropathy (BEN), BEN. See Balkan endemic nephropathy (BEN)

When to Integrate Surgery for Metatstatic Urothelial Cancers

Urothelial Tumors of the Upper Tract: Diagnosis and Management. Daniel Rapoport April 11, 2007 Urology Grand Rounds

Case Report Stereotactic Body Radiotherapy for Localized Ureter Transitional Cell Carcinoma: Three Case Reports

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

ROBOTIC VS OPEN RADICAL CYSTECTOMY

Upper Tract Urothelial Carcinomas (UTUCs)

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Retroperitoneal Laparoscopic Radical Nephroureterectomy for High Urothelial Tumours

Index. Note: Page numbers of article titles are in boldface type.

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

Carcinoma of the Renal Pelvis and Ureter Histopathology

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer

Carcinoma of the Urinary Bladder Histopathology

Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor

ENDOSCOPIC URETERECTOMY DURING NEPHROURETERECTOMY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA

Laparoscopic Radical Nephrectomy- the current gold standard

Procedure related complications and how to prevent them

Upper urinary tract urothelial carcinomas (UTUC)

Long-Term Oncologic Outcome after Laparoscopic Radical Nephroureterectomy for Upper Tract Transitional Cell Carcinoma

Upper Tract Urothelial Cancers Nephron Sparing Strategies

Laparoscopic Nephroureterectomy with Concomitant Open Bladder Cuff Excision

Clinical Study Ureteroscopic Laser Treatment of Upper Urinary Tract Urothelial Cell Carcinomas: Can a Tumour Free Status Be Achieved?

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Kaiser Oakland Urology

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision

Bladder Cancer Guidelines

Non-commercial use only

Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches

Five Views of Transitional Cell Carcinoma: One Man s Journey

PROTOCOL TITLE LYMPHADENECTOMY IN UROTHELIAL CARCINOMA IN THE RENAL PELVIS AND

Robotic distal ureterectomy with psoas hitch and ureteroneocystostomy: Surgical technique and outcomes

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

Complex case Presentations

The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Determination of cell viability after laparoscopic tissue stapling in a porcine model

Lymphadenectomy in RCC: Yes, No, Clinical Trial?

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Bladder Trauma Data Collection Sheet

Presentation of Cases /Audience Voting/Panel/Discussion

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care

Trimodality Therapy for Muscle Invasive Bladder Cancer

Glossary of Terms Primary Urethral Cancer

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Bladder Case # 1. Principal Diagnosis: Bladder Tumor, Suspect Transitional Cell Carcinoma. Secondary Diagnoses: 1. Hypertension. 2. Hyperlipidemia.

EUROPEAN UROLOGY 57 (2010)

UROLOGY CANCER 2009 COMPARATIVE AUDIT REPORT

Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes

Melanoma Quality Reporting

BJUI. Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review COCHRANE REVIEW

How much colon should be resected?

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data

Minimal Invasive Approach ro radical cystectomy: Results of the European multicentric study

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Staging and Grading Last Updated Friday, 14 November 2008

Upper Tract Tcc. Mohan Arianayagam FRACS (Urology)

Surgical Management of Renal Cancer. David Nicol Consultant Urologist

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience

receive adjuvant chemotherapy

Laparoscopic Nephroureterectomy for Upper Tract Transitional Cell Carcinoma: Comparison of Laparoscopic and Open Surgery

Lee et al. World Journal of Surgical Oncology (2018) 16:135

Hierro-Majadahonda, Universidad Aut ó noma de Madrid, Madrid, Spain,

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

Azik Hoffman *, Ofer Yossepowitch, Yaron Erlich, Ronen Holland and David Lifshitz

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Early Experience of Laparoendoscopic Single-Site Nephroureterectomy for Upper Urinary Tract Tumors

UROLOGICAL CANCER 2010 COMPARATIVE AUDIT REPORT

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience

Urothelial carcinomas of the upper urinary tract how does UK practice compare with European guidelines: is there a difference?

BJUI. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort

da Vinci Prostatectomy My Greek personal experience

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Section Activity Activity Description Details Reference(s)

Majid Eshghi, MD, FACS, MBA Valhalla, New York January 2018

Citation International journal of urology (2. Right which has been published in final f

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Videoforum Videosurgery

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer

Disclosures. Personalized Approaches to Gastrointestinal Cancers. Objectives. What is personalized cancer care. Go through some genomic studies

Does the Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Improve Survival in Bladder Cancer?

Urinary Bladder, Ureter, and Renal Pelvis

Robotic assisted laparoscopic radical cystectomy for bladder carcinoma: early experience and oncologic outcomes

Appendix 4 Urology Care Pathways

GUIDELINES ON RENAL CELL CARCINOMA

Transcription:

Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy?

80 patients LNU (n = 40) or ONU (n = 40) CSS (p = 0.2), BRFS (p = 0.86), MFS (p = 0.12) similar for the entire cohort Subgroups of pt3 UTUC and high-grade tumors better CSS and MFS for ONU compared LNU p = 0.04 and p = 0.004, respectively, for pt3 p = 0.01 and p = 0.01, respectively, for high-grade disease

Meta analysis 2012, 21 studies published before 2011 ONU 3093 LNU 1235 Better 5Y CSS for LNU (by 9% av) Same complication rate and periop mortality Same 5Y OS, RFS

N 371 1992-2012 ONU LNU 271 100 3Y IVRFS 59.9 61.7 p 0.267 5Y OS 75.2 59.1 p 0.027 5Y CSS 80.2 66.1 p 0.015 MV analysis only PT3/4 worse PT3/4 OS HR 2.59 p=0.01 PT3/4 CSS HR 2.50 p= 0.005

Published 2017 5 medical centers 2000-2012 ONU LNU 906 615 5Y IVRFS 51% 57.8 0.010 5Y CSS 76.4% 80.4 0.032 5Y OS 71.4% 75.8 0.026 pt3/4 5Y IVRFS (MVA) 54.1 62.9 0.038 5Y CSS 56.9% 64.3 0.022 5Y OS 53.1 60.4 0.018

Meta Analysis; 42 studies till 2016, 7554 pts ONU 4925 LNU2629

Meta Analysis; 42 studies till 2016, 7554 pts ONU 4925 LNU2629 Port site mets Peritoneal carcinomatosis none Oncologic outcomes 6/2629 (0.02%)LNU 39/42 studies equal 3 studies poorer for LNU in T3/4 LND rarely performed, equally distributed between ONU and LNU one study; higher node yield for ONU Bladder cuff done open in 35 LNU, (3 pure lap, 4 endoscopic) 2 studies no bladder cuff in some pts LNU=ONU

Meta Analysis; 42 studies till 2016, 7554 pts ONU 4925 LNU2629 Pathological findings Surgical Margins same <20% Positive Nodes same <17% PT3-4 ratio same Less Primary Ureteral TCC in LNU patients

Meta Analysis; 42 studies till 2016, 7554 pts ONU 4925 LNU2629 Combined Vs Open RNU (16 studies) 1/16 studies poorer oncologic outcome for LNU (The Korean study) 1/16 better 5y CSS for LNU (French study) Pure Lap vs Open RNU 1/3 RCT poorer oncologic outcome for T3/HG LNU (The Italian study) 1/3 poorer RFS for open 1/3 no difference

Meta Analysis; 42 studies till 2016, 7554 pts ONU 4925 LNU2629 Unspecified/heterogenous lap vs open RNU 1/19 trend towards poorer RFS for LNU 1/19 trend towards poorer CSS and RFS for LNU 1/19 BRFS poor for Hand Assisted lap done endoscopically MVA Lap RNU w endoscopic bladder cuff vs open RNU 0/4 showed oncologic inferiority Subgroup of Locally advanced dis (T3/4 and high grade) 4/10 better CSS, OS, RFS for ONU No comparison of retroperitoneal recurrence performed

Meta Analysis; 42 studies till 2016, 7554 pts ONU 4925 LNU2629 Conclusions Oncologic equivalence in most studies However can not be established when the bladder cuff is taken laparoscopically or for T3/4 and HG Assumption Technical difficulty of lap bladder cuff management

Meta analysis of articles published until 2017 1630 patients 792 RANU 838 LNU Mean operative time 298 251 min, P = 0.03 Median node count 5.5 1.0 Positive surgical margins 1.69% 7.06%, P = 0.18 bladder recurrence 24.6% 36.89%, P = 0.09 Distant metastases 27.50% 17.50%, P = 0.29 Disease-specific mortality 7.5% 12.5%, P = 0.46 Perioperative mortality 0.14% 1.32%, P = 0.03 Overall complication rate 12.5% 18.8% P < 0.001

My Guiding Principles for NephroUreterectomy: For the older, frail patient -Is this more a palliative or curative procedure? Is life expectancy long enough to warry about ureteral recurrence? Are positive lymph nodes going to change treatment plan -There are higher surgical risks with 1. Total NephroUreterectomy with bladder cuff vs Nephrectomy 2. Complete suprahilar to pelvic LND vs no LND? In selected pts with no distal ureteral tumor nephrectomy only is appropriate

820 NxUx Pts Intravesical Extravesical Endoscopic 5Y RFS 46% 36% 30% If you do a bladder cuff, do it right! RNU, LNU,ONU

My Guiding Principles for NephroUreterectomy: Technique - The nephrectomy is harder in most cases - First clip the ureter - Always take a classic, visual bladder cuff - Always 2 layers bladder closure and assess for leak intraop with 240cc bladder irrigation -Low threshold to undock, reposition, redock, add trocars, add time. or convert Do not struggle!

2. Lymph node dissection

3. Distal ureter dissection and bladder cuff excision

Thank You

Case Presentation 68 years old male Abdominal pain PMH: Type 2 DM, Hypertension. Social: former smoker. Performed in OSH: CT : 2.3 cm enhancing lobulated mass within left renal pelvis Cystoscopy + Ureteroscopic biopsy: bladder biopsy negative, renal pelvis mass consistent with high grade urothelial carcinoma. Chest X-ray negative.

CT Abdomen and Pelvis 03/27/2018

1. Kidney dissection and clip ureter

Pathology Specimens Left kidney, ureter and bladder cuff. Left parahilar and para-aortic lymph nodes (11) Tumor size: 4.2 x 3.6 x 2.0 cm High-grade papillary urothelial carcinoma, invasive into lamina propria. Surgical margins: negative Regional lymph nodes: no tumor present (0/11) pt1, N0

Post operative management - In a chair and light dinner eve of surgery - Drain 24-48hours - DC Home POD 1 or2 - DC Foley POD 5 - Cystogram only if questionable closure

Post operative management - In a chair and light dinner eve of surgery - Drain 24-48hours - DC Home POD 1 or2 - DC Foley POD 5

https://www.ecrt.org/upload/pdf/crt-2017-417.pdf

https://link.springer.com/content/pdf /10.1007%2Fs00345-015-1712-3.pdf